Vinblastine and prednisolone chemotherapy for surgically excised grade III canine cutaneous mast cell tumours

Veterinary and Comparative Oncology

Volumn 5, Issue 3, 2007, Pages 168-176

  Hayes, Alison ^a   Adams, V ^a   Smith, K ^a   Maglennon, G ^a   Murphy, S ^a  

^a ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

Adjuvant; Canine; Chemotherapy; Cutaneous; Mast cell tumour; Vinblastine

Indexed keywords

CANIS FAMILIARIS;

EID: 47849098941     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2007.00135.x     Document Type: Article

References (24)

1. Dorn CR, Taylor DO, Schneider R, Hibbard HH and Klauber MR. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. Journal of the National Cancer Institute 1968; 40: 307-318.
2. Cohen D, Reif JS, Brodey RS and Keiser H. Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital. Cancer Research 1974; 34: 2859-2868.
3. Gieger TL, Theon AP, Werner JA, McEntee MC, Rassnick KM and Decock HE. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001). Journal of Veterinary Internal Medicine 2003; 17: 687-692.
4. Patnaik A, Ehler WJ and MacEwen EG. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Veterinary Pathology 1984; 21: 469-474.
5. Bostock DE. The prognosis following surgical removal of mastocytomas in dogs. Journal of Small Animal Practice 1973; 14: 27-40.
6. Simoes JP, Schoning P and Butine M. Prognosis of canine mast cell tumors: A comparison of three methods. Veterinary Pathology 1994; 31: 637-647.
7. Murphy S, Sparkes AH, Smith KC, Blunden AS and Brearley MJ. Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection. Veterinary Record 2004; 154: 743-746.
8. Abadie JJ, Amardeilh MA and Delverdier ME. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. Journal of the American Veterinary Medical Association 1999; 215: 1629-1634.
9. Scase TJ, Edwards D, Miller J, Henley W, Smith K, Blunden A and Murphy S. Canine mast cell tumors: Correlation of apoptosis and proliferation markers with prognosis. Journal of Veterinary Internal Medicine 2006; 20: 151-158.
10. Bostock DE. Neoplasms in the skin and subcutaneous tissues in dogs and cats. British Veterinary Journal 1986; 142: 1-19.
11. Chaffin K and Thrall DE. Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis. Veterinary Radiology and Ultrasound 2002; 43: 392-395.
12. Hahn KA, King GK and Carreras JK. Efficacy of radiation therapy for incompletely resected grade-III mast cell tumors in dogs: 31 cases (1987-1998). Journal of the American Veterinary Medical Association 2004; 224: 79-82.
13. Ladue T, Price GS, Dodge R, Page RL and Thrall DE. Radiation therapy for incompletely resected canine mast cell tumors. Veterinary Radiology and Ultrasound 1998; 39: 57-62.
14. Thamm DH, Turek MM and Vail DM. Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 cases. Journal of Veterinary Medicine and Science 2006; 68: 581-587.
15. McCaw DL, Miller MA, Ogilvie GK, Withrow SJ, Brewer WG Jr, Klein MK, Bell FW and Anderson SK. Response of canine mast cell tumors to treatment with oral prednisone. Journal of Veterinary Internal Medicine 1994; 8: 406-408.
16. McCaw DL, Miller MA, Bergman PJ, Withrow SJ, Moore AS, Knapp DW, Fowler D and Johnson JC. Vincristine therapy for mast cell tumors in dogs. Journal of Veterinary Internal Medicine 1997; 11: 375-378.
17. Gerritsen RJ, Teske E, Kraus JS and Rutteman GR. Multi-agent chemotherapy for mast cell tumours in the dog. Veterinary Quarterly 1998; 20: 28-31.
18. Rassnick KM, Moore AS, Williams LE, London CA, Kintzer PP, Engler SJ and Cotter SM. Treatment of canine mast cell tumors with CCNU (Lomustine). Journal of Veterinary Internal Medicine 1999; 13: 601-605.
19. Thamm DH, Mauldin EA and Vail DM. Prednisone and vinblastine chemotherapy for canine mast cell tumor - 41 cases (1992-1997). Journal of Veterinary Internal Medicine 1999; 13: 491-497.
20. Davies DR, Wyatt KM, Jardine JE, Robertson ID and Irwin PJ. Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumours. Journal of the American Animal Hospital Association 2004; 40: 124-130.
21. Owen LN. TNM Classification of Tumours in Domestic Animals. Geneva, World Health Organisation, 1980.
22. Turrel JM, Kitchell BE, Miller LM and Theon A. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs. Journal of the American Animal Hospital Association 1988; 8: 936-940.
23. Thamm DH and Vail DM. In: Small Animal Clinical Oncology, 3rd edn., SJ Withrow and EG MacEwen, eds., Philadelphia, WB Saunders Co, 2001: 261-282.
24. Veterinary Co-operative Oncology Group (VCOG). Veterinary Co-operative Oncology Group - Common Terminology Criteria for Adverse Events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0. Veterinary and Comparative Oncology 2004; 2: 195-213.